The microRNA miR-22 shows potent anti-tumor role, possible therapeutic potential in acute myeloid leukemia

New research by NHGRI scientists and others has shown that a microRNA known as miR-22 reduces the production of cancer cells in mice with acute myeloid leukemia and leukemia. MicroRNAs are small molecules involved in regulating how much a gene is turned on or off. The findings highlighted the possibility of using miR-22-based therapy to treat patients with these cancers. The study was published today, April 26, in the journal Nature Communications.
Source: NHGRI Homepage Highlights - Category: Genetics & Stem Cells Source Type: news